Theranostic Advances in Breast Cancer in Nuclear Medicine

被引：52
|
作者：
Vahidfar, Nasim [1 ]
Aghanejad, Ayuob [2 ]
Ahmadzadehfar, Hojjat [3 ]
Farzanehfar, Saeed [1 ]
Eppard, Elisabeth [4 ,5 ]
机构：
[1] Univ Tehran Med Sci, Vali Asr Hosp, Dept Nucl Med, Tehran 1419733141, Iran
[2] Tabriz Univ Med Sci, Biomed Inst, Res Ctr Pharmaceut Nanotechnol, Tabriz 51368, Iran
[3] Klinikum Westfalen, Dept Nucl Med, D-44149 Dortmund, Germany
[4] Positronpharma SA, Rancagua 878, Santiago 7500621, Chile
[5] Univ Hosp Magdeburg, Dept Nucl Med, Leipziger Str 44, D-39120 Magdedurg, Germany
来源：
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | 2021年 / 22卷 / 09期
关键词：
theranostic; radiopharmaceutical; imaging; therapy; GASTRIN-RELEASING-PEPTIDE; NEUROENDOCRINE TUMORS; BOMBESIN RECEPTORS; PET; EXPRESSION; DIAGNOSIS; SUBTYPES; FIBROBLASTS; LIGANDS; PATIENT;
D O I：
10.3390/ijms22094597
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
The implication of 'theranostic' refers to targeting an identical receptor for diagnostic and therapeutic purposes, by the same radioligand, simultaneously or separately. In regard to extensive efforts, many considerable theranostic tracers have been developed in recent years. Emerging evidence strongly demonstrates the tendency of nuclear medicine towards therapies based on a diagnosis. This review is focused on the examples of targeted radiopharmaceuticals for the imaging and therapy of breast cancer.
引用
收藏
页数：17
相关论文
共 50 条
  • [31] Using Nuclear Medicine Imaging in Clinical Practice: Update on PET to Guide Treatment of Patients With Metastatic Breast Cancer
    Clark, Amy S.
    McDonald, Elizabeth
    Lynch, M. Camilla
    Mankoff, David
    ONCOLOGY-NEW YORK, 2014, 28 (05): : 424 - 430
  • [32] Personalized medicine for breast cancer: it is a new day!
    Russell, Christy A.
    AMERICAN JOURNAL OF SURGERY, 2014, 207 (03) : 321 - 325
  • [33] Recent advances on peptide-based theranostic nanomaterials
    Rong, Lei
    Lei, Qi
    Zhang, Xian-Zheng
    VIEW, 2020, 1 (04)
  • [34] A state-of-the-art review of the recent advances of theranostic liposome hybrid nanoparticles in cancer treatment and diagnosis
    Azimizonuzi, Hannaneh
    Ghayourvahdat, Arman
    Ahmed, Mareb Hamed
    Kareem, Radhwan Abdul
    Zrzor, Athmar Jaber
    Mansoor, Aseel Salah
    Athab, Zainab H.
    Kalavi, Shaylan
    CANCER CELL INTERNATIONAL, 2025, 25 (01)
  • [35] Traditional Chinese Medicine for Breast Cancer: A Review
    Feng, Rui-Qi
    Li, De-Hui
    Liu, Xu-Kuo
    Zhao, Xiao-Hui
    Wen, Qian-Er
    Yang, Ying
    BREAST CANCER-TARGETS AND THERAPY, 2023, 15 : 747 - 759
  • [36] Advances in breast cancer treatment
    Grebic, Damir
    Simac, Daniel, V
    Valkovic, Petra
    GAZZETTA MEDICA ITALIANA ARCHIVIO PER LE SCIENZE MEDICHE, 2019, 178 (06) : 459 - 465
  • [37] Oncological theranostics in nuclear medicine
    Laschinsky, Christina
    Herrmann, Ken
    Fendler, Wolfgang
    Nader, Michael
    Lahner, Harald
    Hadaschik, Boris
    Sandach, Patrick
    ONKOLOGIE, 2022, 28 (07): : 612 - 622
  • [38] Advances in breast cancer imaging
    Tardivon, A.
    Malhaire, C.
    Athanasiou, A.
    Thibault, F.
    El Khoury, C.
    EJC SUPPLEMENTS, 2010, 8 (03): : 22 - 23
  • [39] Radiolabelled porphyrins in nuclear medicine
    Waghorn, Philip A.
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2014, 57 (04) : 304 - 309
  • [40] Nuclear medicine and thyroid cancers in 2024: Iodine 131, PET and new theranostic approaches
    Ciappuctini, Renaud
    Nascimento, Camila
    Edet-Sanson, Agathe
    Bardet, Stephane
    BULLETIN DU CANCER, 2024, 111 (10) : 10S64 - 10S72
12345